Location: Home
  • search
  • go
  • Relate News
  • 11/26/2010Upcoming Event: The Unbreakable Pharma Cold Chain
  • 11/25/2010NDRC to cut prices of MNC essential drug products
  • 11/25/2010Sihuan agrees to take over generic drug player Dupromise
  • 11/24/2010MNCs Escalate China Deals and Investments in the Face of Increased Sho...
  • 11/24/2010Life Expectancy in China Rising Slowly, Despite Economic Surge
  • 11/24/2010Guangzhou Pharma initiates national expansion with two acquisitions
  • 11/24/2010China Medicine appoints new CFO
  • 11/23/2010Foreign trade of medicines and health products up 23.09% in the third ...
  • 11/23/2010Guangdong revises prices of 4,231 drug products
  • 11/23/2010Shanghai pharma to cut retail prices through alliances
  • 11/23/2010SFDA initiates campaign against illegal online drug ads and sales
  • 11/23/2010US Trade Representative Finds Fault with India, China Intellectual Pro...
  • 11/23/2010China Sky One Medical appoints CFO and VP
  • 11/22/2010CRG plans IPO for Beijing Pharma in Hong Kong
  • 11/22/2010Data Monitor: Chinese diabetes drug market to triple in next decade
  • 11/19/2010Novartis' China vaccine acquisition shaky with delayed government appr...
  • 11/19/2010CRG enters strategic alliance with Suzhou Municipal Government
  • 11/19/2010China's needs will drive research at Novartis' Shanghai R&D center
  • 11/19/20103SBio gets 18.83% stake in Isotechnika Pharma
  • 11/19/2010Cipla close to a global supply pact with Pfizer?
  • 11/19/2010Bayer to restructure with new growth strategies
  • 11/18/2010Former SFDA official tried in court for corruption
  • 11/18/2010CDS release survey of type II diabetes self-management by patients
  • 11/17/2010MOH launch new measures to fight rebound of commercial briberies in ho...
  • 11/17/2010Shanxi adds 209 drugs to its essential drug list
  • 11/17/2010CRG expands business in Shandong province with new JV and logistics ce...
  • 11/17/2010Founder Group consolidates pharma businesses into Southwest Synthetic ...
  • 11/17/2010Kelun acquires IV transfusion manufacturer Zhejiang Guojin Pharma
  • 11/17/2010Novartis unveils long-term growth strategy in a changing marketplace
  • 11/17/2010Monitor Group: China to Become Life Science Powerhouse by 2020
  • Page:541/719 Total number of articles:21568: [First][<<] [539] [540] [541] [542] [543] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group